Chronic Lymphocytic Leukaemia

New prognostic markers in this disease have been introduced by the Department and are currently used in the evaluating of patients at diagnosis and directing the choice of appropriate therapy.

Publication

Cl Bacon, P Daly, B Sheane, EC Conneally, PV Browne, S McCann, M Ni Chongaile, R McDermot, D Hollywood, L Wilson, E Vandenberghe.
Successful outcome of patients with relapsed/refractory Hodgkin lymphoma treated with high dose chemotherapy at the National adult Bone Marrow Transplant Unit in St James's Hospital.
Irish Medical Journal. 102, 1, 26-28. 2009.

Amjad Hayat, David O'Brien, Paul O'Rourke, Siobhan McGuckin, Tony Fitzgerald, Eibhlin Conneally, Paul V Browne, Shaun R McCann, Mark P Lawler, Elisabeth Vandenberghe. CD38 expression level and pattern of expression remains a reliable and robust marker of progressive disease in chronic lymphocytic leukemia. Leukemia & Lymphoma. 47 (11): 2371-2379. 2006.

Principle investigators

Principal Investigator	Email	Telephone
Elisabeth Vandenberghe	vandenbe@tcd.ie	+ 353 1 410 3546
A. Hyat

Back to list of Research Projects